Ottimo Pharma
PrivateLast Round
Series A
Dec 19, 2024
Total Funding Raised
$140M
Company Overview
Ottimo Pharma is a biotechnology company that develops pioneering bi-functional medicines and cancer therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ottimo Pharma Comparables
Compare Ottimo Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crescent Biopharma | 82% | |
| Akeso, Inc. | 81% | |
| Summit Therapeutics Inc. | 80% |
Ottimo Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 19, 2024 |
Ottimo Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| Avoro Capital | Series A |
| OrbiMed | Series A |
| Invus Opportunities | Series A |
| J.P. Morgan Life Sciences Private Capital | Series A |
| RTW Investments | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 682% MoM.
- Aug 27, 2025
Partnered with Asimov for cell line development.
Ottimo Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ottimo Pharma's valuation, stock price, and market status.
Is Ottimo Pharma a public or private company?
Ottimo Pharma is a private company.
What is the current stock price of Ottimo Pharma?
Ottimo Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Ottimo Pharma worth (valuation)?
Valuation information for Ottimo Pharma is not publicly available.
Can I buy Ottimo Pharma stock?
Ottimo Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ottimo Pharma's last funding round?
Ottimo Pharma's most recent funding round was Series A on December 19, 2024.
Who are the main investors in Ottimo Pharma?
Key investors in Ottimo Pharma include Avoro Capital, OrbiMed, Samsara BioCapital.
Will Ottimo Pharma IPO soon?
No public IPO plans have been announced for Ottimo Pharma.
How can I track Ottimo Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ottimo Pharma's secondary market activity and sign up for updates.